ClinicalTrials.govpublic full text
A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
advanced gastrointestinal tumors, angiogenesis inhibitor, monoclonal antibody, vascular endothelial growth factor a (vegf-a), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847384
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.